Literature DB >> 2672706

Treatment of craniopharyngiomas--the stereotactic approach in a ten to twenty-three years' perspective. II. Psychosocial situation and pituitary function.

M Sääf1, M Thorén, C G Bergstrand, G Norén, T Rähn, L Tallstedt, E O Backlund.   

Abstract

Fourty-two consecutive patients with craniopharyngioma were treated by "stereotactic approach", i.e. preferentially stereotactic puncture and installation of colloid isotope into cystic tumours and external stereotactic single dose irradiation to solid tumour parts. In a minority of cases, such treatment was less suitable, and surgical removal and/or radiotherapy was used. There was no peroperative mortality. A long-term follow up (observation time 10-23 years) of the 31 patients alive indicated that they were socially well adapted with a high rate of fulltime work and a low rate of intercurrent disease. In spite of substitution therapy for pituitary insufficiency in most cases, the patients were subjectively seldom disturbed by their disease. Our results support a change in the choice of therapy for craniopharyngioma patients, from open neurosurgery to the less invasive stereotactic techniques.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2672706     DOI: 10.1007/bf01402315

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  45 in total

1.  Treatment of craniopharyngiomas--the stereotactic approach in a ten to twenty-three years' perspective. I. Surgical, radiological and ophthalmological aspects.

Authors:  E O Backlund; B Axelsson; C G Bergstrand; A L Eriksson; G Norén; E Ribbesjö; T Rähn; P O Schnell; L Tallstedt; M Sääf
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

2.  Management of craniopharyngioma in children.

Authors:  H J Hoffman; E B Hendrick; R P Humphreys; J R Buncic; D L Armstrong; R D Jenkin
Journal:  J Neurosurg       Date:  1977-08       Impact factor: 5.115

3.  Treatment of craniopharyngiomas.

Authors:  L Leksell; E O Backlund; L Johansson
Journal:  Acta Chir Scand       Date:  1967

4.  Endocrine function, morbidity, and mortality after surgery for craniopharyngioma.

Authors:  K R Lyen; D B Grant
Journal:  Arch Dis Child       Date:  1982-11       Impact factor: 3.791

5.  [Middle-term course of craniopharyngiomas in children as a function of initial therapeutic choice].

Authors:  J Lalau Keraly; F Aubier; P Derome; C Kalifa; J Lemerle; P Canlorbe; J L Chaussain; J C Job
Journal:  Arch Fr Pediatr       Date:  1986-10

6.  The impact of long-term therapy by a multidisciplinary team on the education, occupation and marital status of growth hormone deficient patients after termination of therapy.

Authors:  A Galatzer; O Aran; N Beit-Halachmi; E Nofar; J Rubitchek; A Pertzelan; Z Laron
Journal:  Clin Endocrinol (Oxf)       Date:  1987-08       Impact factor: 3.478

7.  Endocrine and neurologic outcome in childhood craniopharyngioma: Review of effect of treatment in 42 patients.

Authors:  M J Thomsett; F A Conte; S L Kaplan; M M Grumbach
Journal:  J Pediatr       Date:  1980-11       Impact factor: 4.406

8.  Results of treatment for craniopharyngioma.

Authors:  K Mori; H Handa; T Murata; J Takeuchi; S Miwa; K Osaka
Journal:  Childs Brain       Date:  1980

9.  Internal irradiation for cystic craniopharyngioma.

Authors:  T Kobayashi; N Kageyama; K Ohara
Journal:  J Neurosurg       Date:  1981-12       Impact factor: 5.115

10.  Craniopharyngiomas in children.

Authors:  P W Carmel; J L Antunes; C H Chang
Journal:  Neurosurgery       Date:  1982-09       Impact factor: 4.654

View more
  5 in total

Review 1.  Intracavitary therapeutic options in the management of cystic craniopharyngioma.

Authors:  Adrián Cáceres
Journal:  Childs Nerv Syst       Date:  2005-07-19       Impact factor: 1.475

2.  Pathological changes in cystic craniopharyngiomas following intracavital 90yttrium treatment.

Authors:  G T Szeifert; J Julow; F Slowik; K Bálint; F Lányi; E Pásztor
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

3.  Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma.

Authors:  Michael E Sughrue; Isaac Yang; Ari J Kane; Shanna Fang; Aaron J Clark; Derrick Aranda; Igor J Barani; Andrew T Parsa
Journal:  J Neurooncol       Date:  2010-06-10       Impact factor: 4.130

4.  Psychiatric morbidity in adults with hypopituitarism.

Authors:  S Lynch; S Merson; S A Beshyah; E Skinner; P Sharp; R G Priest; D G Johnston
Journal:  J R Soc Med       Date:  1994-08       Impact factor: 18.000

Review 5.  Craniopharyngioma in Children: Long-term Outcomes.

Authors:  Paul Steinbok
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-09-04       Impact factor: 1.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.